The stock has demonstrated strong positive momentum over the observed period, rising from around $55.76 in early October 2025 to a recent close of $63.64. This represents a significant upward trend, culminating in a price near the upper end of its 52-week range. Over the short term, the stock has gained 3.61% over the past month and 18.73% over the past three months, significantly outperforming the broader market as indicated by positive relative strength figures of 8.86 and 23.36, respectively. The current price of $63.64 sits near the top of its 52-week range of $43.57 to $68.24, indicating the stock is trading at a relatively high level. The price has retreated slightly from a recent peak of $67.93 on March 25, 2026, but remains well above its starting point in the data.

Revenue and profitability have shown strong improvement. For Q4 2025, revenue was $2.27 billion, representing a 25.75% year-over-year growth. The net income for the quarter was $677.1 million, yielding a healthy net margin of 29.8%, a significant improvement from the prior-year Q4 margin of 23.1%. The company maintains a conservative financial structure with a debt-to-equity ratio of 0.33, indicating a low reliance on debt financing. Operating cash flow for Q4 2025 was a robust $1.13 billion, and the trailing twelve-month free cash flow stands at $2.85 billion, supporting financial flexibility. Operational efficiency metrics are solid, with a Return on Equity (ROE) of 8.59% and a Return on Assets (ROA) of 5.35% as of the latest data, reflecting effective use of shareholder capital and company assets.